Organization | Field Name | ID | Required |
---|---|---|---|
KCR | COVID-19 - BRM (COVID19BRM) | 80104 | yes |
NAACCR | COVID TEXT RX -- BRM | 2660 | yes |
Use the RX TEXT--BRM field to record information about BRM or immunotherapy delays, discontinuation, or modifications due to COVID-19.
Code | Description |
---|---|
BRM DC D/T COVID-19 | Immunotherapy was not performed due to COVID-19. |
BRM CHG D/T COVID-19 | Type of immounotherapy offered and performed was changed/modified from what is typically recommended due to COVID-19. |
BRM DELAYED D/T COVID-19 | Typical immunotherapy recommended was performed but it was delayed due to COVID-19. |
BRM CHG & DELAYED D/T COVID-19 | Type of immounotherapy offered and performed was changed/modifieddue to COVID-19 and it was delayed. |
BRM DELAYED D/T COVID-19 & GIVEN AS SUB TX AFTER PROGRESSION | Immunotherapy treatment was recommended before but administered after disease progression. |
<blank> | No change or delay of immunotherapy or bone marrow/stem cell transplant treatment due to COVID-19. |
Note: Record the following information for all cancer patients (when applicable) regardless of whether or not they have a COVID-19 diagnosis or test.
- When medical documentation is available to indicate that immunotherapy administration was discontinued or not initiated because of COVID-19 pandemic, record
- BRM DC D/T COVID-19
- When medical documentation is available to indicate that immunotherapy administration was changed/modified (i.e. reduction in the number of cycles) because of COVID-19 pandemic, record
- BRM CHG D/T COVID-19
- When medical documentation is available to indicate that initiation of immunotherapy administration was delayed because of COVID-19 pandemic. record
- BRM DELAYED D/T COVID-19
- When medical documentation is available to indicate that immunotherapy administration was changed/modified (i.e. reduction in the number of cycles) and delayed because of COVID-19 pandemic, record
- BRM CHG & DELAYED D/T COVID-19
- When immunotherapy was recommended before but administered after disease progression, record
- BRM delayed D/T COVID-19 & given as subsequent TX after progression
- Note: Record BRM treatment in Second Course Rx fields
Overview
Content Tools
Activity